Terms: = Pancreatic cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
24 results:
1. Pathologic tumor response to neoadjuvant therapy in resected pancreatic cancer: does it affect prognosis?
Donisi G; Nappo G; Pacilli M; Capretti GL; Spaggiari P; Sollai M; Bozzarelli S; Zerbi A
Updates Surg; 2023 Sep; 75(6):1497-1508. PubMed ID: 37578734
[TBL] [Abstract] [Full Text] [Related]
2. Teledentistry: A Future Solution in the Diagnosis of Oral Lesions: Diagnostic Meta-Analysis and Systematic Review.
Uhrin E; Domokos Z; Czumbel LM; Kói T; Hegyi P; Hermann P; Borbély J; Cavalcante BGN; Németh O
Telemed J E Health; 2023 Nov; 29(11):1591-1600. PubMed ID: 36976779
[No Abstract] [Full Text] [Related]
3. The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study.
Yang L; Su J; Wang W; Zhou F
World J Surg Oncol; 2023 Jan; 21(1):19. PubMed ID: 36691032
[TBL] [Abstract] [Full Text] [Related]
4. Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients.
Gao G; Liao H; Jiang Q; Liu D; Li T
World J Surg Oncol; 2022 Sep; 20(1):315. PubMed ID: 36171631
[TBL] [Abstract] [Full Text] [Related]
5. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
6. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
[TBL] [Abstract] [Full Text] [Related]
7. Knockdown of long non-coding MIR210HG inhibits cell proliferation, migration, and invasion in hepatoblastoma via the microRNA-608-FOXO6 axis.
Duan Y; Wu H; Hao X; Li F; Liu J; Zhu C; Dong Q
J Int Med Res; 2021 Dec; 49(12):3000605211054695. PubMed ID: 34918962
[TBL] [Abstract] [Full Text] [Related]
8. Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort.
Zhan Q; Wen C; Zhao Y; Fang L; Jin Y; Zhang Z; Zou S; Li F; Yang Y; Wu L; Jin J; Lu X; Xie J; Cheng D; Xu Z; Zhang J; Wang J; Deng X; Chen H; Peng C; Li H; Zhang H; Fang H; Wang C; Shen B
EBioMedicine; 2021 Dec; 74():103716. PubMed ID: 34839264
[TBL] [Abstract] [Full Text] [Related]
9. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
10. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
Lv Y; Wang Z; Li K; Wang Q; Bai W; Yuan X; Yu T; Niu J; Yang Z; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; Guo W; Luo B; Li X; Yuan J; Han N; Zhu Y; He C; Yin Z; Fan D; Han G
Hepatology; 2021 Apr; 73(4):1478-1493. PubMed ID: 32706906
[TBL] [Abstract] [Full Text] [Related]
11. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated cancer Cell Death.
Froeling FEM; Swamynathan MM; Deschênes A; Chio IIC; Brosnan E; Yao MA; Alagesan P; Lucito M; Li J; Chang AY; Trotman LC; Belleau P; Park Y; Rogoff HA; Watson JD; Tuveson DA
Clin Cancer Res; 2019 Dec; 25(23):7162-7174. PubMed ID: 31527169
[TBL] [Abstract] [Full Text] [Related]
12. CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine.
Sonbol MB; Ahn DH; Goldstein D; Okusaka T; Tabernero J; Macarulla T; Reni M; Li CP; O'Neil B; Van Cutsem E; Bekaii-Saab T
Future Oncol; 2019 Apr; 15(12):1295-1302. PubMed ID: 30768369
[TBL] [Abstract] [Full Text] [Related]
13. A Comparative Analysis of Survival and Funding Discrepancies in cancers With High Mortality.
Hall BR; Cannon A; Atri P; Wichman CS; Smith LM; Kumar S; Batra SK; Wang H; Ganti AK; Sasson AR; Are C
Ann Surg; 2020 Feb; 271(2):296-302. PubMed ID: 30188400
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos JP; Palmer DH; Ghaneh P; Psarelli EE; Valle JW; Halloran CM; Faluyi O; O'Reilly DA; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Anthoney A; Lind P; Glimelius B; Falk S; Izbicki JR; Middleton GW; Cummins S; Ross PJ; Wasan H; McDonald A; Crosby T; Ma YT; Patel K; Sherriff D; Soomal R; Borg D; Sothi S; Hammel P; Hackert T; Jackson R; Büchler MW;
Lancet; 2017 Mar; 389(10073):1011-1024. PubMed ID: 28129987
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative defining system for pancreatic head cancer considering surgical resection.
Yang SJ; Hwang HK; Kang CM; Lee WJ
World J Gastroenterol; 2016 Jul; 22(26):6076-82. PubMed ID: 27468199
[TBL] [Abstract] [Full Text] [Related]
16. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
[TBL] [Abstract] [Full Text] [Related]
17. Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.
Sclafani F; Chau I; Cunningham D; Lampis A; Hahne JC; Ghidini M; Lote H; Zito D; Tabernero J; Glimelius B; Cervantes A; Begum R; De Castro DG; Wilson SH; Peckitt C; Eltahir Z; Wotherspoon A; Tait D; Brown G; Oates J; Braconi C; Valeri N
Carcinogenesis; 2016 Sep; 37(9):852-7. PubMed ID: 27381831
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant Trametinib Delays the Outgrowth of Occult pancreatic cancer in a Mouse Model of Patient-Derived Liver Metastasis.
Newhook TE; Lindberg JM; Adair SJ; Kim AJ; Stelow EB; Rahma OE; Parsons JT; Bauer TW
Ann Surg Oncol; 2016 Jun; 23(6):1993-2000. PubMed ID: 26847682
[TBL] [Abstract] [Full Text] [Related]
19. Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer.
Lindberg JM; Newhook TE; Adair SJ; Walters DM; Kim AJ; Stelow EB; Parsons JT; Bauer TW
Neoplasia; 2014 Jul; 16(7):562-71. PubMed ID: 25117978
[TBL] [Abstract] [Full Text] [Related]
20. Association between gestational diabetes mellitus and subsequent risk of cancer: a systematic review of epidemiological studies.
Tong GX; Cheng J; Chai J; Geng QQ; Chen PL; Shen XR; Liang H; Wang DB
Asian Pac J Cancer Prev; 2014; 15(10):4265-9. PubMed ID: 24935382
[TBL] [Abstract] [Full Text] [Related]
[Next]
